Updated in docs.google now. Both new scripts (2,832) and refilled scripts (2,212) are YTD high. On the other hand, L (89,451) and L (77,709) are down from last week numbers.
Overall, numbers show good progress. From now on, the Tier-2 coverage increase will start show up more on the weekly scripts.
Sentiment: Strong Buy
just being conservative. 20,000 Rx's per month x184= $3.68 million 12 months=$44 million. IF AMRN gets Anchor then much higher. BP has to know that if they took over this product the sales would be through the roof.
many thx Cincy for the numbers; indeed steady growth trend;
stock is now since 3 days on reversal mode and volumes have been significantly higher (except yesterday just a bit higher), presume that wise shorts are starting to cover....and some likely go long in addition...
Now expecting a nice run-up as Panel gets closer and then the question is (in case of a nice panel, like say a 10 to 1 positive) whether some decent offer comes before or after Dec FDA...